0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Genmab AS - Trending symbols

Latest News of Genmab AS

DateTitleRead
2025-01-22
12:23
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024Read



Trends

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Accumulated Other Comprehensive Income 19,795-11,4318,3646,69115,05517,56432,620-80,852-48,232
Total Other Income Expense Net 22,655-8,51414,141165,079179,221194,661373,881-971,428-597,546
Depreciation and Amortization 23,088-17,8935,195202,886208,081-13,709194,372-482,684-288,311

Comments

How you think about this?

Leave a comment

Stay informed about Genmab AS.

Receive notifications about Genmab AS in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.